Five web-portals under FDA scanner for selling drugs, FIRs against three

Mumbai: Five web-portals have come under the radar of the Food and Drug Administration (FDA) for selling prescription drugs online. While the FDA has already registered First Information Reports (FIRs) against three such e-pharmacies – MeraPharmacy.com, mChemist.com and Healercart.com, the process of initiating action against the other two – Pharmeasy.in and Netmed.com – is under way. According to information accessed from the FDA, police have started investigations against the first three e-pharmacies.
Three accused have also been arrested in connection with sale and supply to MeraPharmacy.com. For the two other websites, FDA officials have approached the Park Site police station in Vikhroli and the Kherwadi police station in Bandra.”These websites were found selling drugs, both those available over the counter and scheduled ones, through an online system. It is considered illegal under our current provisions and we are initiating necessary action,” a joint commissioner from FDA said. In the absence of a guideline to streamline online pharmacy, web portals continue to receive notices from the FDA to not dispense medicines online. Under the Drug & Cosmetics Act, 1940 and the Drug & Cosmetics Rules, 1945, online sale of drugs is prohibited. In PharmEasy.in, customers are given a 20% discount on medicines and 40% discount on diagnostic tests while at Merapharmacy.com, apart from discounted drugs, a facility for timely reminder for taking medicine before or after meals is also available. In mChemist, however, sale of scheduled drugs and psychotropic substances is not available.
A lot of these web portals also offer online service through Whats App on which customers can upload their prescription and get medicines delivered at their doorstep. In Netmeds.com, a facility to consult doctors online immediately for a free prescription is also available. FDA officials said that an order was first placed by them through these websites before issuing notices.
Last year, about 20 websites were issued notices in Maharashtra for selling prescription drugs online, including e-giant Snapdeal, which sold 45 drugs, and Shopclues.com.
“We are also taking action against chemist shops that are supplying drugs to these websites,” an FDA official said. Currently, a notice has been issued to a chemist in Vikhroli for supplying drugs to Pharmacy. in for e-sale. Data from FDA shows that in 2015-16, a total of 166 licences of retail and wholesale chemists were cancelled while licenses of 335 others were suspended for various violations under Drug and Cosmetics Act. Of these, 105 chemist’s licenses were cancelled because no pharmacist was found at the shop during inspection.
FDA officials claim a similar situation is mirrored in e-pharmacy, where based on prescription, a medicine is dispensed but not actually inspected by registered pharmacist. Chemists and pharmacists have voiced massive opposition to e-pharmacy; the central government has now formed a committee, headed by Maharashtra FDA commissioner Harshdeep Kamble, to come up with guidelines for e-pharmacies to function. Four meetings have been conducted on this matter.
  • Related Posts

    Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical Specialties

    For commercial-scale production of 14 complex excipients The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties Private…

    Delhi High Court slams Baba Ramdev for new video targeting Rooh Afza

    The Delhi High Court on Thursday came down heavily on yoga guru Baba Ramdev for allegedly releasing a fresh video targeting Hamdard, despite an earlier undertaking to refrain from making…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    ED raids three pharma units in Baddi, Nalagarh

    ED raids three pharma units in Baddi, Nalagarh

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations